Abstract
Non-founder total target cash compensation in 2016 increased 4.2% year-over-year at private life sciences companies and 6% at private technology companies.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
